Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jun;64(6):2180–2187. doi: 10.1128/iai.64.6.2180-2187.1996

Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

G P Andrews 1, D G Heath 1, G W Anderson Jr 1, S L Welkos 1, A M Friedlander 1
PMCID: PMC174053  PMID: 8675324

Abstract

As a first step in formulating an improved plague vaccine, we developed a simple purification strategy that produced high yields of pure cell-associated and culture supernatant-derived fraction 1 capsular antigen (F1) from both avirulent Yersinia pestis C092 (Pgm- Lcr-) and an Escherichia coli F1-producing recombinant strain. Cell-associated F1 was partially purified by sequential ammonium sulfate precipitations of a sodium chloride extract of acetone-dried bacteria harvested from broth cultures. Cell-free F1 was precipitated directly from culture supernatants with a single application of 30% ammonium sulfate. By exploiting the aggregative property of F1, large quantities of purified high-molecular-weight F1 species from both cell extracts and supernatants were isolated in the void volume of a preparative gel filtration column. Highly purified, endotoxin-free F1, combined with two different adjuvants, induced very high F1 titers in mice and protected them against either subcutaneous (70 to 100% survival) or aerosol (65 to 84% survival) challenge with virulent organisms. This protection was independent of the source of the antigen and the adjuvant used. F1-induced protection against both subcutaneous and aerosol challenge was also significantly better than that conferred by immunization with the licensed killed whole-cell vaccine. Our results indicate that F1 antigen represents a major protective component of previously studied crude capsule preparations, and immunity to F1 antigen provides a primary means for the host to overcome plague infection by either the subcutaneous or respiratory route.

Full Text

The Full Text of this article is available as a PDF (335.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER E. E., SOMMER H., FOSTER L. E., MEYER E., MEYER K. F. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J Immunol. 1952 Feb;68(2):131–145. [PubMed] [Google Scholar]
  2. Bennett L. G., Tornabene T. G. Characterization of the antigenic subunits of the envelope protein of Yersinia pestis. J Bacteriol. 1974 Jan;117(1):48–55. doi: 10.1128/jb.117.1.48-55.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bolivar F., Rodriguez R. L., Greene P. J., Betlach M. C., Heyneker H. L., Boyer H. W., Crosa J. H., Falkow S. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene. 1977;2(2):95–113. [PubMed] [Google Scholar]
  4. Cavanaugh D. C., Elisberg B. L., Llewellyn C. H., Marshall J. D., Jr, Rust J. H., Jr, Williams J. E., Meyer K. F. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J Infect Dis. 1974 May;129(Suppl):S37–S40. doi: 10.1093/infdis/129.supplement_1.s37. [DOI] [PubMed] [Google Scholar]
  5. Chen T. H., Elberg S. S. Scanning electron microscopic study of virulent Yersinia pestis and Yersinia pseudotuberculosis type 1. Infect Immun. 1977 Mar;15(3):972–977. doi: 10.1128/iai.15.3.972-977.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. EHRENKRANZ N. J., MEYER K. F. Studies on immunization against plague. VIII. Study of three immunizing preparations in protecting primates against pneumonic plague. J Infect Dis. 1955 Mar-Apr;96(2):138–144. doi: 10.1093/infdis/96.2.138. [DOI] [PubMed] [Google Scholar]
  7. ENGELSBERG E., LEVY J. B. Studies on immunization against plague. VI. Growth of pasteurella pestis and the production of the envelope and other soluble antigens in a casein hydrolyzate mineral glucose medium. J Bacteriol. 1954 Apr;67(4):438–449. doi: 10.1128/jb.67.4.438-449.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Galyov E. E., Karlishev A. V., Chernovskaya T. V., Dolgikh D. A., Smirnov OYu, Volkovoy K. I., Abramov V. M., Zav'yalov V. P. Expression of the envelope antigen F1 of Yersinia pestis is mediated by the product of caf1M gene having homology with the chaperone protein PapD of Escherichia coli. FEBS Lett. 1991 Jul 29;286(1-2):79–82. doi: 10.1016/0014-5793(91)80945-y. [DOI] [PubMed] [Google Scholar]
  9. Galyov E. E., Smirnov OYu, Karlishev A. V., Volkovoy K. I., Denesyuk A. I., Nazimov I. V., Rubtsov K. S., Abramov V. M., Dalvadyanz S. M., Zav'yalov V. P. Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. Putative T and B cell epitopes. FEBS Lett. 1990 Dec 17;277(1-2):230–232. doi: 10.1016/0014-5793(90)80852-a. [DOI] [PubMed] [Google Scholar]
  10. HIGUCHI K., SMITH J. L. Studies on the nutrition and physiology of Pasteurella pestis. VI. A differential plating medium for the estimation of the mutation rate to avirulence. J Bacteriol. 1961 Apr;81:605–608. doi: 10.1128/jb.81.4.605-608.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karlyshev A. V., Galyov E. E., Abramov V. M., Zav'yalov V. P. Caf1R gene and its role in the regulation of capsule formation of Y. pestis. FEBS Lett. 1992 Jun 22;305(1):37–40. doi: 10.1016/0014-5793(92)80650-6. [DOI] [PubMed] [Google Scholar]
  12. Karlyshev A. V., Galyov E. E., Smirnov OYu, Guzayev A. P., Abramov V. M., Zav'yalov V. P. A new gene of the f1 operon of Y. pestis involved in the capsule biogenesis. FEBS Lett. 1992 Feb 3;297(1-2):77–80. doi: 10.1016/0014-5793(92)80331-a. [DOI] [PubMed] [Google Scholar]
  13. LAWTON W. D., FUKUI G. M., SURGALLA M. J. Studies on the antigens of Pasteurella pestis and Pasteurella pseudotuberculosis. J Immunol. 1960 May;84:475–479. [PubMed] [Google Scholar]
  14. Lee S. F. Active release of bound antibody by Streptococcus mutans. Infect Immun. 1995 May;63(5):1940–1946. doi: 10.1128/iai.63.5.1940-1946.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Martin D. G., Jarvis F. G., Milner K. C. Physicochemical and biological properties of sonically treated Vi antigen. J Bacteriol. 1967 Nov;94(5):1411–1416. doi: 10.1128/jb.94.5.1411-1416.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Meyer K. F. Effectiveness of live or killed plague vaccines in man. Bull World Health Organ. 1970;42(5):653–666. [PMC free article] [PubMed] [Google Scholar]
  17. Meyer K. F., Hightower J. A., McCrumb F. R. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis. J Infect Dis. 1974 May;129(Suppl):S41–S45. doi: 10.1093/infdis/129.supplement_1.s41. [DOI] [PubMed] [Google Scholar]
  18. Oyston P. C., Williamson E. D., Leary S. E., Eley S. M., Griffin K. F., Titball R. W. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect Immun. 1995 Feb;63(2):563–568. doi: 10.1128/iai.63.2.563-568.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pautov V. N., Chicherin Iu V., Evstigneev V. I., Byvalov A. A., Kedrov O. A. Protektivnye svoistva fraktsii I chumnogo mikroba v éksperimente. Zh Mikrobiol Epidemiol Immunobiol. 1979 Oct;(10):37–42. [PubMed] [Google Scholar]
  20. SPECK R. S., WOLOCHOW H. Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus. J Infect Dis. 1957 Jan-Feb;100(1):58–69. doi: 10.1093/infdis/100.1.58. [DOI] [PubMed] [Google Scholar]
  21. Simpson W. J., Thomas R. E., Schwan T. G. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am J Trop Med Hyg. 1990 Oct;43(4):389–396. doi: 10.4269/ajtmh.1990.43.389. [DOI] [PubMed] [Google Scholar]
  22. Surgalla M. J., Beesley E. D. Congo red-agar plating medium for detecting pigmentation in Pasteurella pestis. Appl Microbiol. 1969 Nov;18(5):834–837. doi: 10.1128/am.18.5.834-837.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tsai C. M., Frasch C. E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982 Jan 1;119(1):115–119. doi: 10.1016/0003-2697(82)90673-x. [DOI] [PubMed] [Google Scholar]
  24. Vorontsov E. D., Dubichev A. G., Serdobintsev L. N., Naumov A. V. Association-dissociation processes and supermolecular organisation of the capsule antigen (protein F1) of Yersinia pestis. Biomed Sci. 1990 Apr;1(4):391–396. [PubMed] [Google Scholar]
  25. Williams J. E., Cavanaugh D. C. Measuring the efficacy of vaccination in affording protection against plague. Bull World Health Organ. 1979;57(2):309–313. [PMC free article] [PubMed] [Google Scholar]
  26. Williams R. C., Jr, Gewurz H., Quie P. G. Effects of fraction I from Yersinia pestis on phagocytosis in vitro. J Infect Dis. 1972 Sep;126(3):235–241. doi: 10.1093/infdis/126.3.235. [DOI] [PubMed] [Google Scholar]
  27. Zakrevskii V. I., Plekhanova N. G. Izuchenie protektivnykh svoistv antigensoderzhashchikh liposom razlichnogo lipidnogo sostava pri chume. Vestn Akad Med Nauk SSSR. 1990;(8):41–44. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES